U
CEMI

UBS’s Chembio diagnostics, Inc. CEMI Stock Holding History

UBS’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$8K Buy
+2,122
New +$7.42K ﹤0.01% 9127
2014
Q2 		– Sell
-181
Closed -$1K – 11430
2014
Q1 		$1K Sell
181
-4,945
-96% -$17.4K ﹤0.01% 10334
2013
Q4 		$17K Buy
5,126
+4,624
+921% +$16.3K ﹤0.01% 8399
2013
Q3 		$2K Buy
+502
New +$2.13K ﹤0.01% 10094

Other funds holding CEMI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $637M AUM 39.08% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

UBS's CEMI Position: Q3 2014 in Review

UBS opened a new position in Chembio diagnostics, Inc. (CEMI) in Q3 2014: 2,122 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #9127 among its holdings. This is a return to the name: UBS previously reported a position in CEMI as recently as Q1 2014.

UBS first reported a position in CEMI in Q3 2013 and has held it in 4 quarters since. The position peaked at $17K in Q4 2013. 18 funds tracked by Wall St. Rank hold CEMI as of Q3 2014.

  • UBS held 2,122 shares of Chembio diagnostics, Inc. worth $8K as of Q3 2014.
  • Chembio diagnostics, Inc. was a new UBS position in Q3 2014.
  • Chembio diagnostics, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9127 holding.
  • UBS first reported a position in Chembio diagnostics, Inc. in Q3 2013 and has held it in 4 quarters since.
  • UBS's Chembio diagnostics, Inc. position peaked at $17K in Q4 2013.
  • 18 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.